Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes

10.1055/a-2075-9968

Aktualisierungshinweis

Die DDG-Praxisempfehlungen werden regelmäßig zur zweiten Jahreshälfte aktualisiert. Bitte stellen Sie sicher, dass Sie jeweils die neueste Version lesen und zitieren.

Publication History

Received: 26 June 2025

Accepted: 08 August 2025

Article published online:
24 December 2025

• Literatur

• 1 Bergenstal RM, Gavin JR. 3rd, Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005; 118: 1S-6S
• 2 Mazze RS, Strock E, Stout P. et al. A Novel Methodology to Evaluate Continuous Glucose Monitoring Accuracy and Clinical Representation of Glucose Exposure and Variability. Diabetes 2007; 56: A107-A107
• 3 International Organization for Standardization. In vitro diagnostic test systems – Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013) 2015.
• 4 Eichenlaub M, Pleus S, Rothenbuhler M. et al. Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes Technol Ther 2024; 26: 263-275
• 5 Schlüter S, Freckmann G, Heinemann L. et al. Evaluierung des SPECTRUM-Schulungs- und Behandlungsprogramms zum rtCGM: eine multizentrische, prospektive Studie aus der Praxis bei 120 Erwachsenen mit Diabetes. Diabetol Stoffwechs 2021; 30: 85-94
• 6 Deutsche Diabetes Gesellschaft. S3-Leitlinie Therapie des Typ-1-Diabetes 2023. AWMF online. Accessed July 01, 2024 at: https://register.awmf.org/assets/guidelines/057–013l_S3-Therapie-Typ-1-Diabetes_2023–09_1.pdf
• 7 American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes—2024. Diabetes Care 2024; 47: S126-S144
• 8 Pleus S, Baumstark A, Jendrike N. et al. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015. BMJ Open Diabetes Res Care 2020; 8: e001067
• 9 Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen – Rili-BÄK. Deutsches Ärzteblatt Online 2023. Accessed July 01, 2024 at: https://www.rfb.bio/pdf/Rili-BAEK-05–2023.pdf
• 10 Thomas A, Schlüter S, Naudorf M. et al. Einsatz und Evidenz des Kontinuierlichen Glukosemonitorings (CGM) bei Menschen mit DIabetes, überwiegend behandelt mit ICT. Diabetes Stoffw Herz 2022; 31: 92-109
• 11 Phillip M, Nimri R, Bergenstal RM. et al. Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocr Rev 2023; 44: 254-280
• 12 Deiss D, Waldenmaier D, Carstensen S. et al. Steckbriefe für Systeme zur Automatisierten Insulin-Dosierung. Diabetes Stoffwechsel Herz 2022; 31: 36-43
• 13 Lin R, Brown F, James S. et al. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med 2021; 38: e14528
• 14 2. Auflage. Version 3.
• 15 ElSayed NA, Aleppo G, Aroda VR. et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care 2023; 46: S111-S127
• 16 Danne T, Nimri R, Battelino T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-1640
• 17 Battelino T, Danne T, Bergenstal RM. et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019; 42: 1593-1603
• 18 Freckmann G, Wehrstedt S, Eichenlaub M. et al. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care 2025; 48: 1213-1217
• 19 Diedisheim M, Pecquet C, Julla JB. et al. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study. Diabetes Technol Ther 2023; 25: 279-286
• 20 Lange K, Kulzer B. Psychologische Aspekte der kontinuierlichen Glukosemessung (CGM). Diabetes Stoffwechsel Herz 2023; 23: 180-189
• 21 Bergenstal RM, Ahmann AJ, Bailey T. et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol 2013; 7: 562-578
• 22 Bergenstal RM, Beck RW, Close KL. et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018; 41: 2275-2280
• 23 Deutsche Diabetes Gesellschaft. S3-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kinders- und Jugendalter. AWMF online; 2023. Accessed July 01, 2024 at: https://register.awmf.org/assets/guidelines/057–016l_S3_Diagnostik-Therapie-Verlaufskontrolle-Diabetes-mellitus-Kinder-Jugendliche_2023–11.pdf